Skip to content

Released Jul 9, 2013, during market hours

10-Q filed Jul 9, 2013, 9 days after period end · 0001477932-13-003117

Q2 2013 · 10-Q
Revenue—
Net Income-$1.37MN/M vs Q2 2012N/M vs Q1 2013
EPS Diluted-$0.31no prior Q2 2012 on fileN/M vs Q1 2013
Operating Income-$1,373,212—
Operating Cash Flowderived-$448—
Free Cash Flowderived-$448—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2013Q2 2012
Net Income-$1.37M-$61.23K
EPS Diluted-$0.31—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR